30549331|t|Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
30549331|a|OBJECTIVE: To use digital histology in a large autopsy cohort of Lewy body disorder (LBD) patients with dementia to test the hypotheses that co-occurring Alzheimer disease (AD) pathology impacts the anatomic distribution of alpha-synuclein (SYN) pathology and that co-occurring neocortical tau pathology in LBDs associates with worse cognitive performance and occurs in a pattern differing from AD. METHODS: Fifty-five autopsy-confirmed LBD (Parkinson disease with dementia, n = 36; dementia with Lewy bodies, n = 19) patients and 25 AD patients were studied. LBD patients were categorized as having moderate/severe AD copathology (SYN + AD = 20) or little/no AD copathology (SYN-AD = 35). Digital measures of tau, beta-amyloid (Abeta), and SYN histopathology in neocortical and subcortical/limbic regions were compared between groups and related to antemortem cognitive testing. RESULTS: SYN burden was higher in SYN + AD than SYN-AD in each neocortical region (F1, 54 = 5.6-6.0, p < 0.02) but was equivalent in entorhinal cortex and putamen (F1, 43-49 = 0.7-1.7, p > 0.2). SYN + AD performed worse than SYN-AD on a temporal lobe-mediated naming task (t27 = 2.1, p = 0.04). Antemortem cognitive test scores inversely correlated with tau burden (r = -0.39 to -0.68, p < 0.05). AD had higher tau than SYN + AD in all regions (F1, 43 = 12.8-97.2, p < 0.001); however, SYN + AD had a greater proportion of tau in the temporal neocortex than AD (t41 = 2.0, p < 0.05), whereas AD had a greater proportion of tau in the frontal neocortex than SYN + AD (t41 = 3.3, p < 0.002). SYN + AD had similar severity and distribution of neocortical Abeta compared to AD (F1, 40-43 = 1.6-2.0, p > 0.1). INTERPRETATION: LBD patients with AD copathology harbor greater neocortical SYN pathology. Regional tau pathology relates to cognitive performance in LBD dementia, and its distribution may diverge from pure AD. Tau copathology contributes uniquely to the heterogeneity of cognitive impairment in LBD. Ann Neurol 2018; 1-13 ANN NEUROL 2019;85:259-271.
30549331	41	44	Tau	Gene	4137
30549331	58	77	Lewy Body Disorders	Disease	MESH:D020961
30549331	144	162	Lewy body disorder	Disease	MESH:D020961
30549331	164	167	LBD	Disease	MESH:D020961
30549331	169	177	patients	Species	9606
30549331	183	191	dementia	Disease	MESH:D003704
30549331	233	250	Alzheimer disease	Disease	MESH:D000544
30549331	252	254	AD	Disease	MESH:D000544
30549331	303	318	alpha-synuclein	Gene	6622
30549331	320	323	SYN	Gene	23336
30549331	369	372	tau	Gene	4137
30549331	386	390	LBDs	Disease	
30549331	474	476	AD	Disease	MESH:D000544
30549331	516	519	LBD	Disease	MESH:D020961
30549331	521	552	Parkinson disease with dementia	Disease	MESH:C537240
30549331	562	587	dementia with Lewy bodies	Disease	MESH:D020961
30549331	597	605	patients	Species	9606
30549331	613	615	AD	Disease	MESH:D000544
30549331	616	624	patients	Species	9606
30549331	639	642	LBD	Disease	MESH:D020961
30549331	643	651	patients	Species	9606
30549331	695	697	AD	Disease	MESH:D000544
30549331	711	714	SYN	Gene	23336
30549331	717	719	AD	Disease	MESH:D000544
30549331	739	741	AD	Disease	MESH:D000544
30549331	755	758	SYN	Gene	23336
30549331	759	761	AD	Disease	MESH:D000544
30549331	789	792	tau	Gene	4137
30549331	808	813	Abeta	Gene	351
30549331	820	823	SYN	Gene	23336
30549331	968	971	SYN	Gene	23336
30549331	993	996	SYN	Gene	23336
30549331	999	1001	AD	Disease	MESH:D000544
30549331	1007	1010	SYN	Gene	23336
30549331	1011	1013	AD	Disease	MESH:D000544
30549331	1154	1157	SYN	Gene	23336
30549331	1160	1162	AD	Disease	MESH:D000544
30549331	1184	1187	SYN	Gene	23336
30549331	1188	1190	AD	Disease	MESH:D000544
30549331	1313	1316	tau	Gene	4137
30549331	1356	1358	AD	Disease	MESH:D000544
30549331	1370	1373	tau	Gene	4137
30549331	1379	1382	SYN	Gene	23336
30549331	1385	1387	AD	Disease	MESH:D000544
30549331	1445	1448	SYN	Gene	23336
30549331	1451	1453	AD	Disease	MESH:D000544
30549331	1482	1485	tau	Gene	4137
30549331	1517	1519	AD	Disease	MESH:D000544
30549331	1551	1553	AD	Disease	MESH:D000544
30549331	1582	1585	tau	Gene	4137
30549331	1616	1619	SYN	Gene	23336
30549331	1622	1624	AD	Disease	MESH:D000544
30549331	1649	1652	SYN	Gene	23336
30549331	1655	1657	AD	Disease	MESH:D000544
30549331	1711	1716	Abeta	Gene	351
30549331	1729	1731	AD	Disease	MESH:D000544
30549331	1780	1783	LBD	Disease	MESH:D020961
30549331	1784	1792	patients	Species	9606
30549331	1798	1800	AD	Disease	MESH:D000544
30549331	1840	1843	SYN	Gene	23336
30549331	1864	1867	tau	Gene	4137
30549331	1914	1926	LBD dementia	Disease	MESH:D020961
30549331	1971	1973	AD	Disease	MESH:D000544
30549331	1975	1978	Tau	Gene	4137
30549331	2036	2056	cognitive impairment	Disease	MESH:D003072
30549331	2060	2063	LBD	Disease	MESH:D020961
30549331	Association	MESH:D020961	23336
30549331	Association	MESH:D003072	23336
30549331	Association	MESH:D000544	23336

